Classical trigeminal neuralgia (CTN) is treated predominantly by pharmacotherapy but side effects and unsuccessful occurs. The current study was carried out to evaluate the therapeutic effect of combination of pharmacotherapy and lidocaine block. Thirteen patients with CTN managed with pharmacotherapy were recruited and assigned either to no additional treatment (Group I) or to additional analgesic block (Group II). The primary endpoint was the reduction in the frequency of pain episodes in a month assessed at 30 and 90 days. Comparisons of measurements of pain, general health and depression scales were secondary endpoints. The results from the follow-up visits at 30 and 90 days showed the Group II to have larger reduction in the frequency of pain and exhibited a bigger improvement in the scores of the pain, general health and depression scales. The results from this preliminary study suggest a clinical benefit of the combination of pharmacotherapy and lidocaine block.

Combination of pharmacotherapy and lidocaine analgesic block of the peripheral trigeminal branches for trigeminal neuralgia: a pilot study / DI STANI, Fabrizio; Ojango, Christine; Dugoni, Demo; Di Lorenzo, Luigi; Masala, Salvatore; Delfini, Roberto; Bruti, Gianluca; Simonetti, Giovanni; Piovesan, Elcio Juliato; Ruggeri, Andrea Gennaro. - In: ARQUIVOS DE NEURO-PSIQUIATRIA. - ISSN 0004-282X. - 73:8(2015), pp. 660-664. [10.1590/0004-282X20150077]

Combination of pharmacotherapy and lidocaine analgesic block of the peripheral trigeminal branches for trigeminal neuralgia: a pilot study

DI STANI, FABRIZIO;Dugoni, Demo;Delfini, Roberto;BRUTI, Gianluca;Ruggeri, Andrea Gennaro
2015

Abstract

Classical trigeminal neuralgia (CTN) is treated predominantly by pharmacotherapy but side effects and unsuccessful occurs. The current study was carried out to evaluate the therapeutic effect of combination of pharmacotherapy and lidocaine block. Thirteen patients with CTN managed with pharmacotherapy were recruited and assigned either to no additional treatment (Group I) or to additional analgesic block (Group II). The primary endpoint was the reduction in the frequency of pain episodes in a month assessed at 30 and 90 days. Comparisons of measurements of pain, general health and depression scales were secondary endpoints. The results from the follow-up visits at 30 and 90 days showed the Group II to have larger reduction in the frequency of pain and exhibited a bigger improvement in the scores of the pain, general health and depression scales. The results from this preliminary study suggest a clinical benefit of the combination of pharmacotherapy and lidocaine block.
2015
Analgesic block; Classical trigeminal neuralgia; Lidocaine; Treatment; Aged; Analgesics; Anesthetics, Local; Combined Modality Therapy; Female; Humans; Lidocaine; Male; Middle Aged; Nerve Block; Pain Measurement; Pilot Projects; Reproducibility of Results; Severity of Illness Index; Time Factors; Treatment Outcome; Trigeminal Nerve; Trigeminal Neuralgia; Neurology (clinical); Biological Psychiatry
01 Pubblicazione su rivista::01a Articolo in rivista
Combination of pharmacotherapy and lidocaine analgesic block of the peripheral trigeminal branches for trigeminal neuralgia: a pilot study / DI STANI, Fabrizio; Ojango, Christine; Dugoni, Demo; Di Lorenzo, Luigi; Masala, Salvatore; Delfini, Roberto; Bruti, Gianluca; Simonetti, Giovanni; Piovesan, Elcio Juliato; Ruggeri, Andrea Gennaro. - In: ARQUIVOS DE NEURO-PSIQUIATRIA. - ISSN 0004-282X. - 73:8(2015), pp. 660-664. [10.1590/0004-282X20150077]
File allegati a questo prodotto
File Dimensione Formato  
Di-Stano_Combination_2015.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 231.84 kB
Formato Adobe PDF
231.84 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1072382
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 14
social impact